Search
Find a recruiting study
7,120 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Oct 26, 2026). No sign-up needed.
Most recently updated studies · page 44 of 297
- RecruitingHealthy volunteersPhase 3
PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study
ARJ Medical, Inc.
- Location
- Doral, FL + 2 other US sites
- Eligibility basics
- Ages 3–17
- RecruitingHealthy volunteersPhase 3
PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study
ARJ Medical, Inc.
- Location
- Doral, FL + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics
OncoHost Ltd.
- Location
- Dallas, TX
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 2
Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers
Hera Biotech, Inc.
- Location
- Corpus Christi, TX + 1 other US site
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingHealthy volunteers
Collection and Distribution of Biospecimens for Novel Research Uses
iSpecimen Inc
- Location
- Huntsville, AL
- Eligibility basics
- Ages 1 mo–89
- RecruitingHealthy volunteersPhase 2/Phase 3
Effect of Early Administration of TXA in Adult Hip Fractures
Ascension Health
- Location
- Grand Blanc, MI
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles
Cytrellis Biosystems, Inc.
- Location
- New York, NY
- Eligibility basics
- Ages 40–70
- RecruitingHealthy volunteers
Study to Evaluate the Efficacy of a Micro Coring Device for the Treatment of Scars of the Cytrellis Micro-Coring Device for the Treatment of Scars
Cytrellis Biosystems, Inc.
- Location
- Miami, FL
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Otsuka Pharmaceutical Development & Commercialization, Inc.
- Location
- Washington D.C., DC + 5 other US sites
- Eligibility basics
- Ages 1 mo–18
- Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics
- Location
- Birmingham, AL + 64 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Encoded Therapeutics
- Location
- San Francisco, CA + 9 other US sites
- Eligibility basics
- Ages 6 mo–17
- RecruitingPhase 3
[18F]PI-2620 Phase 3 Histopathological Study
Lantheus Biosciences Ltd.
- Location
- Phoenix, AZ + 16 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Birmingham, AL + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Ipsen
- Location
- Tucson, AZ + 26 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
Hoffmann-La Roche
- Location
- Birmingham, AL + 10 other US sites
- Eligibility basics
- Ages 1 mo–11
- RecruitingPhase 3
A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
PTC Therapeutics
- Location
- Indianapolis, IN
- Eligibility basics
- Up to age 9
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche
- Location
- Birmingham, AL + 121 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Birmingham, AL + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Merck Sharp & Dohme LLC
- Location
- Sun City, AZ + 70 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 1
Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
Verve Therapeutics, Inc.
- Location
- Garden Grove, CA + 4 other US sites
- Eligibility basics
- Ages 18–70
- Recruiting
Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
VisCardia Inc.
- Location
- Indianapolis, IN + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
LEO Pharma
- Location
- Birmingham, AL + 21 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
CRISPR Therapeutics
- Location
- La Jolla, CA + 7 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
Debiopharm International SA
- Location
- Los Angeles, CA + 9 other US sites
- Eligibility basics
- Ages 18+
Data source: deploy-time snapshot of the ClinicalTrials.gov API. How we list studies